Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents

November 1, 2023; Volume 64,Issue 11

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine November 1, 2023, 64 (11) 10A;

Discussions with Leaders

  • You have access
    Advancing Nuclear Medicine at the Multiomics Intersection
    Kalevi Kairemo and Johannes Czernin
    Journal of Nuclear Medicine November 1, 2023, 64 (11) 1671-1673; DOI: https://doi.org/10.2967/jnumed.123.266793

Hot Topics

  • You have access
    FAPI PET/CT Immune-Fibrosis Imaging for New Insights into Rheumatologic Disorders
    Christian Schmidkonz, Armin Atzinger, Andreas Ramming and Torsten Kuwert
    Journal of Nuclear Medicine November 1, 2023, 64 (11) 1674-1675; DOI: https://doi.org/10.2967/jnumed.123.266182

Focus on Molecular Imaging

  • You have access
    The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection
    Signore Alberto, Alvaro A. Ordonez, Chanda Arjun, Gurpreet Kaur Aulakh, Nicolas Beziere, Ekaterina Dadachova, Thomas Ebenhan, Ulises Granados, Aruna Korde, Amirreza Jalilian, Wening Lestari, Archana Mukherjee, Milos Petrik, Tamer Sakr, Clara L. Santos Cuevas, Mick M. Welling, Jan Rijn Zeevaart, Sanjay K. Jain and David M. Wilson
    Journal of Nuclear Medicine November 1, 2023, 64 (11) 1676-1682; DOI: https://doi.org/10.2967/jnumed.123.265906

Oncology

  • Clinical

    • Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using <sup>18</sup>F-FET PET
      Open Access
      Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using 18F-FET PET
      Johannes Lohmeier, Helena Radbruch, Winfried Brenner, Bernd Hamm, Anna Tietze and Marcus R. Makowski
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1683-1689; DOI: https://doi.org/10.2967/jnumed.123.265642
    • Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      You have access
      Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
      Maeve A. Hennessy, Jeffrey P. Leal, Chiung-Yu Huang, Lilja B. Solnes, Rita Denbow, Vandana G. Abramson, Lisa A. Carey, Minetta C. Liu, Mothaffar Rimawi, Jennifer Specht, Anna Maria Storniolo, Vicente Valero, Christos Vaklavas, Eric P. Winer, Ian E. Krop, Antonio C. Wolff, Ashley Cimino-Mathews, Richard L. Wahl, Vered Stearns and Roisin M. Connolly
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1690-1696; DOI: https://doi.org/10.2967/jnumed.123.265853
    • INVITED PERSPECTIVE

      • You have access
        18F-FDG PET “Metabolic Response” to Neoadjuvant Systemic Therapy for Breast Cancer: Quo Vadis?
        Geraldine Gebhart
        Journal of Nuclear Medicine November 1, 2023, 64 (11) 1697-1698; DOI: https://doi.org/10.2967/jnumed.123.266303
    • High Tumor Uptake on <sup>18</sup>F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      You have access
      High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
      Ophélie De Rycke, Marine Perrier, Éric Ouvrard, Clément Mennetrey, Choaib Lachachi, Aurélie Bando-Delaunay, David Morland, Bernard Goichot, David Taieb, Thomas Walter, Guillaume Cadiot, Jérôme Cros, Olivia Hentic, Philippe Ruszniewski, Rachida Lebtahi, Alessio Imperiale and Louis de Mestier
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1699-1705; DOI: https://doi.org/10.2967/jnumed.123.265584
    • Validation of the ΔSUV<sub>max</sub> for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial
      You have access
      Validation of the ΔSUVmax for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial
      Emmanuel Itti, Paul Blanc-Durand, Alina Berriolo-Riedinger, Salim Kanoun, Françoise Kraeber-Bodéré, Michel Meignan, Elodie Gat, Steven Le Gouill, René-Olivier Casasnovas and Caroline Bodet-Milin
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1706-1711; DOI: https://doi.org/10.2967/jnumed.123.265871
    • Impact of <sup>68</sup>Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Open Access
      Impact of 68Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
      Stefan A. Koerber, Manuel Röhrich, Leon Walkenbach, Jakob Liermann, Peter L. Choyke, Christoph Fink, Cathrin Schroeter, Anna-Maria Spektor, Klaus Herfarth, Thomas Walle, Jeremie Calais, Hans-Ulrich Kauczor, Dirk Jaeger, Juergen Debus, Uwe Haberkorn and Frederik L. Giesel
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1712-1720; DOI: https://doi.org/10.2967/jnumed.123.266046

Theranostics

  • Clinical

    • BRIEF COMMUNICATION

      • You have access
        Prediction of Resistance to 177Lu-PSMA Therapy by Assessment of Baseline Circulating Tumor DNA Biomarkers
        Oliver Sartor, Elisa Ledet, Minqui Huang, Jennifer Schwartz, Alex Lieberman, Brian Lewis, Jodi Layton, Pedro Barata, Albert Jang, Madeline Hawkins, Olivia Pocha, Sree Lanka and Kendra Harris
        Journal of Nuclear Medicine November 1, 2023, 64 (11) 1721-1725; DOI: https://doi.org/10.2967/jnumed.123.266167
      • [<sup>177</sup>Lu]Lu-PSMA-617 Versus Docetaxel in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Final Survival Analysis of a Phase 2 Randomized, Controlled Trial
        You have access
        [177Lu]Lu-PSMA-617 Versus Docetaxel in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Final Survival Analysis of a Phase 2 Randomized, Controlled Trial
        Swayamjeet Satapathy, Bhagwant Rai Mittal, Ashwani Sood, Chandan Krushna Das, Ravimohan Suryanarayan Mavuduru, Shikha Goyal, Jaya Shukla and Shrawan Kumar Singh
        Journal of Nuclear Medicine November 1, 2023, 64 (11) 1726-1729; DOI: https://doi.org/10.2967/jnumed.123.266141
    • Antihormonal-Treatment Status Affects <sup>68</sup>Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer
      You have access
      Antihormonal-Treatment Status Affects 68Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer
      Kilian Kluge, David Haberl, Holger Einspieler, Sazan Rasul, Sebastian Gutschmayer, Lukas Kenner, Gero Kramer, Bernhard Grubmüller, Shahrokh Shariat, Alexander Haug and Marcus Hacker
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1730-1736; DOI: https://doi.org/10.2967/jnumed.123.265980
    • Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with <sup>177</sup>Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis
      You have access
      Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with 177Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis
      Vishnu Murthy, Andrei Gafita, Pan Thin, Kathleen Nguyen, Tristan Grogan, John Shen, Alexandra Drakaki, Matthew Rettig, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1737-1743; DOI: https://doi.org/10.2967/jnumed.122.265155
    • FEATURED ARTICLE OF THE MONTH

      • Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers
        You have access
        Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers
        Thomas A. Hope, Matthias Benz, Fei Jiang, Daniel Thompson, Francesco Barbato, Roxana Juarez, Miguel Hernandez Pampaloni, Martin Allen-Auerbach, Pawan Gupta, Wolfgang P. Fendler and Jeremie Calais
        Journal of Nuclear Medicine November 1, 2023, 64 (11) 1744-1747; DOI: https://doi.org/10.2967/jnumed.123.265916
    • INVITED PERSPECTIVE

      • You have access
        Out with the Old, in with the New: Can We Bridge the Gap Between Clinical Trial Results Based on Bone Scans and the Era of Modern Prostate Cancer Imaging?
        Michal Eifer, Ramin Alipour, Michael S. Hofman and Aravind S. Ravi Kumar
        Journal of Nuclear Medicine November 1, 2023, 64 (11) 1748-1749; DOI: https://doi.org/10.2967/jnumed.123.266025
    • A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
      You have access
      A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
      Jingliang Zhang, Fei Kang, Jie Gao, Jianhua Jiao, Zhiyong Quan, Shuaijun Ma, Yu Li, Shikuan Guo, Zeyu Li, Yuming Jing, Keying Zhang, Fa Yang, Donghui Han, Weihong Wen, Jing Zhang, Jing Ren, Jing Wang, Hongqian Guo and Weijun Qin
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1750-1757; DOI: https://doi.org/10.2967/jnumed.122.265001
    • Prediction of Response to <sup>177</sup>Lu-PSMA Therapy Based on Tumor-to-Kidney Ratio on Pretherapeutic PSMA PET/CT and Posttherapeutic Tumor-Dose Evaluation in mCRPC
      You have access
      Prediction of Response to 177Lu-PSMA Therapy Based on Tumor-to-Kidney Ratio on Pretherapeutic PSMA PET/CT and Posttherapeutic Tumor-Dose Evaluation in mCRPC
      Melanie Hohberg, Manuel Reifegerst, Alexander Drzezga, Markus Wild and Matthias Schmidt
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1758-1764; DOI: https://doi.org/10.2967/jnumed.122.264953
    • Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of <sup>177</sup>Lu-PSMA I&amp;T
      You have access
      Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of 177Lu-PSMA I&T
      Amir Karimzadeh, Paula Soeiro, Benedikt Feuerecker, Charlotte-Sophie Hecker, Karina Knorr, Matthias M. Heck, Robert Tauber, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber and Isabel Rauscher
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1765-1771; DOI: https://doi.org/10.2967/jnumed.123.265878
  • Basic

    • Tandem Isotope Therapy with <sup>225</sup>Ac- and <sup>177</sup>Lu-PSMA-617 in a Murine Model of Prostate Cancer
      Open Access
      Tandem Isotope Therapy with 225Ac- and 177Lu-PSMA-617 in a Murine Model of Prostate Cancer
      Catherine Meyer, Andreea Stuparu, Katharina Lueckerath, Jeremie Calais, Johannes Czernin, Roger Slavik and Magnus Dahlbom
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1772-1778; DOI: https://doi.org/10.2967/jnumed.123.265433

Adiobiology/Dosimetry

  • Clinical

    • Lesion Dosimetry for [<sup>177</sup>Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer
      You have access
      Lesion Dosimetry for [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer
      Milan Grkovski, Joseph A. O’Donoghue, Brandon S. Imber, George Andl, Cheng Tu, Daniel Lafontaine, Jazmin Schwartz, Maria Thor, Michael J. Zelefsky, John L. Humm and Lisa Bodei
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1779-1787; DOI: https://doi.org/10.2967/jnumed.123.265763
    • BRIEF COMMUNICATION

      • You have access
        Second Symposium of the European Working Group on the Radiobiology of Molecular Radionuclide Therapy
        Julie Nonnekens, Bart Cornelissen and Samantha Y.A. Terry; on behalf of the European Working Group on the Radiobiology of Molecular Radiotherapy
        Journal of Nuclear Medicine November 1, 2023, 64 (11) 1788-1790; DOI: https://doi.org/10.2967/jnumed.123.265956

Radiochemistry

  • Basic

    • Optimized Methods for the Production of High-Purity <sup>203</sup>Pb Using Electroplated Thallium Targets
      You have access
      Optimized Methods for the Production of High-Purity 203Pb Using Electroplated Thallium Targets
      Shefali Saini, Jennifer L. Bartels, Jean-Pierre K. Appiah, Jason H. Rider, Nicholas Baumhover, Michael K. Schultz and Suzanne E. Lapi
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1791-1797; DOI: https://doi.org/10.2967/jnumed.123.265976

Neurology

  • Clinical

    • Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      You have access
      Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
      Alexandra Gogola, Brian J. Lopresti, Dana Tudorascu, Beth Snitz, Davneet Minhas, Vincent Doré, Milos D. Ikonomovic, C. Elizabeth Shaaban, Cristy Matan, Pierrick Bourgeat, N. Scott Mason, Howard Aizenstein, Chester A. Mathis, William E. Klunk, Christopher C. Rowe, Oscar L. Lopez, Ann D. Cohen, Victor L. Villemagne and for the Alzheimer’s Disease Neuroimaging Initiative
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1798-1805; DOI: https://doi.org/10.2967/jnumed.123.265941

Gastroenterology

  • Basic

    • FEATURED BASIC SCIENCE ARTICLE

      • Detection of IL12/23p40 via PET Visualizes Inflammatory Bowel Disease
        You have access
        Detection of IL12/23p40 via PET Visualizes Inflammatory Bowel Disease
        Farzaneh Rezazadeh, Nicholas Ramos, Allen-Dexter Saliganan, Najeeb Al-Hallak, Kang Chen, Bashar Mohamad, Wendy N. Wiesend and Nerissa T. Viola
        Journal of Nuclear Medicine November 1, 2023, 64 (11) 1806-1814; DOI: https://doi.org/10.2967/jnumed.123.265649

Physics and Instrumentation

  • Clinical

    • Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for <sup>89</sup>Zr-Trastuzumab
      You have access
      Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for 89Zr-Trastuzumab
      Philipp Mohr, Joyce van Sluis, Laura Providência, Johannes H. van Snick, Marjolijn N. Lub-de Hooge, Antoon T. Willemsen, Andor W.J.M. Glaudemans, Ronald Boellaard, Adriaan A. Lammertsma, Adrienne H. Brouwers and Charalampos Tsoumpas
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1815-1820; DOI: https://doi.org/10.2967/jnumed.123.265621
    • Total-Body Multiparametric PET Quantification of <sup>18</sup>F-FDG Delivery and Metabolism in the Study of Coronavirus Disease 2019 Recovery
      Open Access
      Total-Body Multiparametric PET Quantification of 18F-FDG Delivery and Metabolism in the Study of Coronavirus Disease 2019 Recovery
      Yiran Wang, Lorenzo Nardo, Benjamin A. Spencer, Yasser G. Abdelhafez, Elizabeth J. Li, Negar Omidvari, Abhijit J. Chaudhari, Ramsey D. Badawi, Terry Jones, Simon R. Cherry and Guobao Wang
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1821-1830; DOI: https://doi.org/10.2967/jnumed.123.265723
    • Total-Body Perfusion Imaging with [<sup>11</sup>C]-Butanol
      You have access
      Total-Body Perfusion Imaging with [11C]-Butanol
      Elizabeth J. Li, Javier E. López, Benjamin A. Spencer, Yasser Abdelhafez, Ramsey D. Badawi, Guobao Wang and Simon R. Cherry
      Journal of Nuclear Medicine November 1, 2023, 64 (11) 1831-1838; DOI: https://doi.org/10.2967/jnumed.123.265659

Illustrated Post

  • You have access
    Obstructive Sialadenitis from Oral Squamous Cell Carcinoma: [68Ga]Ga-FAPI-46 PET–Positive and [18F]FDG PET–Negative
    Peter George Maliha, Abie H. Mendelsohn, Johannes Czernin, Taylor Howard, Jeremie Calais and Masatoshi Hotta
    Journal of Nuclear Medicine November 1, 2023, 64 (11) 1839-1840; DOI: https://doi.org/10.2967/jnumed.123.265498

Letters to the Editor

  • You have access
    HER2-Low Breast Cancer Can Be Visualized by HER2 PET
    Renske Altena, Siri af Burén, Thuy Tran and Rimma Axelsson
    Journal of Nuclear Medicine November 1, 2023, 64 (11) 1841; DOI: https://doi.org/10.2967/jnumed.123.266101
  • You have access
    Reply to: HER2-Low Breast Cancer Can Be Visualized by HER2 PET
    Romain-David Seban
    Journal of Nuclear Medicine November 1, 2023, 64 (11) 1841-1842; DOI: https://doi.org/10.2967/jnumed.123.266490
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 64 (11)
Journal of Nuclear Medicine
Vol. 64, Issue 11
November 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers
  • Detection of IL12/23p40 via PET Visualizes Inflammatory Bowel Disease
Sign up for alerts

Jump to

  • This Month in JNM
  • Discussions with Leaders
  • Hot Topics
  • Focus on Molecular Imaging
  • Oncology
    • Clinical
      • INVITED PERSPECTIVE
  • Theranostics
    • Clinical
      • BRIEF COMMUNICATION
      • FEATURED ARTICLE OF THE MONTH
      • INVITED PERSPECTIVE
    • Basic
  • Adiobiology/Dosimetry
    • Clinical
      • BRIEF COMMUNICATION
  • Radiochemistry
    • Basic
  • Neurology
    • Clinical
  • Gastroenterology
    • Basic
      • FEATURED BASIC SCIENCE ARTICLE
  • Physics and Instrumentation
    • Clinical
  • Illustrated Post
  • Letters to the Editor
  • Most Cited
  • Most Read
Loading
  • Total-Body PET Multiparametric Imaging of Cancer Using a Voxelwise Strategy of Compartmental Modeling
  • Initial Clinical Experience with 90Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 Patients
  • 68Ga-FAPI as a Diagnostic Tool in Sarcoma: Data from the 68Ga-FAPI PET Prospective Observational Trial
  • MIRD Pamphlet No. 27: MIRDcell V3, a Revised Software Tool for Multicellular Dosimetry and Bioeffect Modeling
  • Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using 177Lu-FAP-2286: First-in-Humans Results
More...
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire